Drag a card by its title · ⚙ to size, swap or remove

The company

Shattuck Labs, Inc.

STTK · Nasdaq

Health CareBiotechnologyNot moving yet

STTK stood above a rising 150-day average in 46 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 16.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 2
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $500K
Insider sales, 12 months: $1.2M
Officials’ trades on record: 0
Institutions holding: 95 (+19)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 46 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1

Sale orders, 12 months6

Buyers · sellers1 · 2

Who	Did	Shares	Traded
Abhinav A. ShuklaChief Technical Officer	sold	410at $7.01	2 Jul 2026filed 7 Jul 2026
Abhinav A. ShuklaChief Technical Officer	sold	100at $7.07	1 Jul 2026filed 2 Jul 2026
Arundathy N. PanditeChief Medical Officer	sold	30,000at $7.01	30 Jun 2026filed 2 Jul 2026
Abhinav A. ShuklaChief Technical Officer	sold	23,365at $7.08	30 Jun 2026filed 2 Jul 2026
Orbimed Advisors LlcDirector	bought	1,041,667	11 Jun 2026filed 15 Jun 2026
Orbimed Advisors LlcDirector	bought	208,333	11 Jun 2026filed 15 Jun 2026
Mona AshiyaDirector	bought	1,041,667	11 Jun 2026filed 15 Jun 2026
Mona AshiyaDirector	bought	208,333	11 Jun 2026filed 15 Jun 2026
Clay B. SiegallDirector	bought	62,500at $4.00	9 Jun 2026filed 11 Jun 2026
Arundathy N. PanditeChief Medical Officer	sold	30,000at $6.61	12 May 2026filed 14 May 2026
Abhinav A. ShuklaChief Technical Officer	sold	2,032at $7.01	12 May 2026filed 14 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders95+19 on the quarter

New · exited37 · 20

Reported value$468.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
ADAGE CAPITAL PARTNERS GP, L.L.C.added · filed 14 Aug 2026	8,122,179$56.4M	+3,477,222+74.9%
Redmile Group, LLCadded · filed 14 Aug 2026	6,892,033$47.8M	+1,352,309+24.4%
ORBIMED ADVISORS LLCunchanged · filed 14 Aug 2026	6,306,127$43.8M	00.0%
Prosight Management, LPadded · filed 14 Aug 2026	5,957,877$41.3M	+953,438+19.1%
BlackRock, Inc.added · filed 7 Aug 2026	3,935,810$27.3M	+3,425,004+670.5%
Frazier Life Sciences Management, L.P.new · filed 14 Aug 2026	3,750,000$26.0M	+3,750,000
NEXTBio Capital Management LPadded · filed 14 Aug 2026	3,727,348$25.9M	+577,441+18.3%
Deep Track Capital, LPnew · filed 14 Aug 2026	3,706,734$25.7M	+3,706,734
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	3,207,865$22.3M	+930,689+40.9%
PINNACLE ASSOCIATES LTDadded · filed 3 Aug 2026	1,871,442$13.0M	+503,219+36.8%